Quest Diagnostics (NYSE:DGX) had its target price upped by equities research analysts at Morgan Stanley from $98.00 to $104.00 in a research report issued to ...
Quest Diagnostics (NYSE:DGX) had its price target hoisted by Citigroup from $93.00 to $102.00 in a report released on Wednesday, April 24th, The Fly reports.
ValuEngine upgraded shares of Quest Diagnostics (NYSE:DGX) from a sell rating to a hold rating in a report issued on Wednesday, April 24th, ValuEngine ...
More than a dozen Marlborough-based companies are looking to fill 200 jobs at the Marlborough Works! annual job fair.
The Advanced research report on Global Cervical Cancer Screening Market Segmented by manufacturers, regions, type, and application Focus on key ...
Cellular Health Screening Market by New Innovations, Applications, Technology Updates and Forecast To 2025 – TeloYears, Spectracell Laboratories, Life ...
Sell-side analysts often undertake stock analysis to give their opinions of whether they believe that shares should be bought, sold, or held. Using ratings.
There are many different tools to determine whether a company is profitable or not. One of the most popular ratios is the “Return on Assets” (aka.